The first generation was a glass encased injectable microstimulator with an external tantalum capacitor electrode. This second generation device is a ceramic cylinder, approximately 10 times stronger than the glass case, with platinum electrodes. Zener diodes protect the electronics from defibrillation shocks and from electrostatic discharge. It also contains an unexposed hermetically sealed capacitor that cannot be inadvertently damaged by a steel scalpel. This microstimulator referred to as the Bion TM , is the main component of a 255-channel wireless stimulating system.
Introduction
The Bion TM system is a wireless network of up to 255 single-channel stimulators controlled and powered by an RF link from a central controller. Each stimulator is a ceramic cylinder capped with an anode and a cathode, one on each end. The cylinder is 15.6 mm long and 2.5 mm in diameter. Each stimulator produces asymmetric biphasic capacitively coupled constantcurrent pulses. Pulse width (0 to 500 µsec), pulse amplitude (0 to 40 mA) and pulse frequency (0 to 3,472 pps shared among all active Bion TM stimulators) are controlled digitally by the controller via a 2 MHz AC magnetic link. [1] [2] [3] [4] [5] [6] [7] 
Methods
Prior to the in-vivo testing, Bion TM stimulators underwent a 1,000-hour burn-in test. In this test 31 Bion TM devices operated for 1,000-hour each at an elevated temperature of 125ºC while being operated at a maximum energy level for this temperature. The 250 micron walled ceramic cylinders are brazed to the metal endcap and cylinder at either end. The case was subjected to a dull blade crush and a pull test.
To protect the Bion TM from defibrillator shocks and from electrostatic discharge, bipolar zener diodes were installed around the electronics module. These zeners can protect against 25,000 volts, 10 microseconds electrostatic discharge and against a 0.3 amp defibrillator pulse.
A highly reliable low leakage tested 7 µfd. 30 volt tantalum capacitor was installed for the series output circuit.
In-vivo Tests

A. Surgical Preparation
Experiments were carried out on 10 rats (4-5 months old, 280 -300 g, female). Buprenorphine (0.02 -0.05 mg/kg, s.c.) was given as an analgesic. Anesthesia was induced with Ketamine (80 -100 mg/kg, ip) and Xylazine (8 mg/kg, ip), and maintained with 30% of the first initial dosage (frequency as needed).
Rats were divided into two groups. Rats in the Control Group (n=5) were implanted with two passive controls over the sciatic nerve at the mid-thigh level: an empty Bion TM casing in the left hindlimb, and a silicone rod (Silastic, Baxter, Deerfield, IL; Silicone, NuSil technology, Carpinteria, CA) same size and shape as a Bion TM in the right hindlimb. Animals in the Study Group (n=6) were implanted with four devices: one Bion TM in each hindlimb (same position as passive implants in the Control Group) and the two passive controls were implanted in both sides of the thoracic spine. To insert the implants in the hindlimbs, the sciatic nerve was exposed at the thigh level by separating the fascia and dissecting deeper between the vastus lateralis muscle and the biceps muscle. A 1-2 cm long tunnel was dissected along the mid-thigh exposing the sciatic nerve. The Bion TM was oriented so that the cathode was inserted towards the knee (the anode was then closer to the hip joint) (figure 1). The fascial layer and the skin layers were then closed. Implants were not sutured. To implant the passive controls in the back area, a mid line skin incision was made midway along the thoracic spine. The underlying muscle fascial (covering) layer was separated about 1 cm off the midline. A 1-2 cm long tunnel was dissected at 45 degrees outwards so that the Bion TM casing/silicon rod could be inserted. The fascial layer was sutured closed. The other side was done similarly. The skin was then closed. 
B. Stimulation
After surgery, animals recovered for two weeks. Animals in the Study Group were placed into rodent restrainers (Harvard Apparatus, Holliston, MA) and then into the transmitting coil that send data and power to the Bion TM stimulators in groups of three animals at the same time. In all but one animal, the Bion TM implanted in the left leg was set as inactive and the stimulation settings were programmed to zero. Stimulation settings (Pulse Width, Pulse Amplitude) required to produce threshold twitches of the muscles were determined for each active Bion TM . The Current amplitude used during daily stimulation was set in order to produce a strong visible twitch (usually twice the threshold). Three animals were stimulated with a stimulation pattern of 25-s OFF period and 5-s ON period at 20 Hz. The other three animals were stimulated with a stimulation pattern of 5-s OFF period and 5-s ON period at 20 Hz. In all the animals, stimulus trains were applied starting at two 20-min sessions a day and finishing with three 1-h sessions a day, four to five days a week, for a period of up to five months.
C. Measurements
In order to verify the implant location X-rays were taken after the 2-week recovery period and before the explantation. To take x-rays, animals were anesthetized with isofluorane gas, 1.5 -2.5 % via facemask. Thresholds to produce a palpable muscle were measured twice a month for every implanted Bion TM . The daily stimulation was video recorded.
D. Tissue Processing
Animals were euthanized using pentobarbital S (100 mg/kg, ip). Passive implants and their surrounding tissues were dissected from the back mid thoracic area. Each rear leg containing a Bion TM was also dissected. All the samples were preserved in 10% neutral buffered formalin and sent to a commercial lab (Pathology Research Laboratory, Berkeley, CA).
Implants were removed and each muscle sample containing fibrous tissue capsule was divided in three segments including anterior, middle and posterior levels. The corresponding segment of Sciatic nerve at the various regions was also included. The sections were sent to HistoTec Laboratory (Hayward, CA) for tissue processing and hematoxylin and eosin slide preparations. Selected slides were further stained with Siever-Munger and Cresyl Echt Violet stains to evaluate the nerve fibers.
Results
All 31 units successfully passed the 1,000-hour burning test. When comparing the device parameters before and after the burn-in, only the 10 microamps recharge current was altered.
The average 10 microamps recharge current increased by about 4 microamps and the maximum increase in recharge current was 6.7 microamps. The changes in the 0, 100, and 500 microamps recharge current were negligible.
The ceramic case crushes at approximately 50 psi in the dull blade crush test and the glass Bion TM crushes at 5 psi. The ceramic-metal brazed case pulls apart at approximately 50 pounds.
Based on these tests, receiving inspections tests are set at 20 pounds.
All Bion TM devices stimulated and produced muscle contractions in the legs during the total duration of the study. The twitches were well tolerated by the animals, which usually slept during the stimulation period. During the study period, thresholds were measured for each implanted device, including the inactive Bion TM devices. These thresholds did not change significantly over the study period and rather decreased when compared to those values measured right after the implantation and the first days of stimulation. No device migration was found.
All sections of the leg muscles implanted with Bion TM or silicone tubing had similar fibrous tissue reaction (encapsulation). The round capsules consisted of compact laminated layers of fibro-collagenous tissue varying from 50 to 100 microns in thickness. There was varying degrees of mononuclear cells infiltration, primarily small macrophages and lymphocytes, within the capsular walls.
Polymorphonuclear cells (neutrophils) were rare. Sciatic nerves and/or nerve branches were usually evident in each of the sections. Microscopically, they were within normal limits. The two special stains confirmed cellular integrity of the nerve sections (figure 2). 
Conclusions
All of the tests performed to date indicate that the Bion TM is safe and effective for long-term human implant. Additional tests are being planned prior to human studies
Bion
TM technology partnership
The Bion TM is a natural platform for most FES applications. To move as rapidly as possible to introduce the Bion TM to the FES community for the large variety of applications, we have developed the BionTech Partnership vehicle.
We are proposing an online community -"Bion TM Technology Partnership" or "BionTech" -which will share and exchange ideas and information concerning Bion TM FES applications. We will support this community by providing Bion TM devices, technical support, regulatory assistance and other services.
With the Bion TM device we have decided that the best way to develop applications is through collaboration with the research community. We believe that this would be the best way to take advantage of the Bion TM stimulators potential to be used in a diverse manner. Using the Bion TM , many FES research teams could bypass the costly and time consuming process of developing their own stimulating devices, thus allowing researchers to concentrate on their core scientific disciplines. Moreover, in some cases, the Bion TM architecture, with its small dimensions and wireless connectivity could serve as an enabling technology for projects that otherwise could not have been realized.
